AbbVie Inc (ABBV)
Debt-to-assets ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total assets | US$ in thousands | 135,161,000 | 143,422,000 | 141,937,000 | 148,874,000 | 134,711,000 | 136,221,000 | 135,367,000 | 134,544,000 | 138,805,000 | 141,325,000 | 143,186,000 | 143,211,000 | 146,529,000 | 148,858,000 | 147,972,000 | 150,501,000 | 150,565,000 | 149,621,000 | 149,530,000 | 91,199,000 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $135,161,000K
= 0.00
The debt-to-assets ratio for AbbVie Inc has consistently been 0.00 based on the data provided from March 31, 2020, to December 31, 2024. This indicates that AbbVie has not relied on debt financing to fund its operations and investments over this period. A debt-to-assets ratio of 0.00 suggests that the company's total assets are fully financed by equity, which can be seen as a positive indicator of financial health and stability. It implies that AbbVie has a strong financial position with no significant debt burden relative to its asset base. This low debt-to-assets ratio may also indicate that the company has little financial risk associated with its capital structure, as it does not have a high level of debt obligations that could potentially strain its operations or cash flow.
Peer comparison
Dec 31, 2024